查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医学图像分析软件市场：按类型、按模式、按应用、按最终用户：机会分析和行业预测，2022-2031 年
市场调查报告书
商品编码
1266400

全球医学图像分析软件市场：按类型、按模式、按应用、按最终用户：机会分析和行业预测，2022-2031 年

Medical Image Analysis Software Market By Type, By Modality, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2022-2031
出版日期: | 出版商: Allied Market Research | 英文 220 Pages | 商品交期: 2-3个工作天内

价格

医学图像分析软件市场在 2021 年价值 39 亿美元，预计到 2031 年将达到 123 亿美元，2022 年至 2031 年的复合年增长率为 12.2%。

医学图像分析软件应用程序可以对许多模式的医学图像进行定量分析和可视化，例如 PET、MRI、CT 或显微术。 支持手动和自动分析 3D 医学图像的应用程序为医疗保健提供者和患者带来了广泛的机会。 这包括促进早期诊断以提高治愈率和存活率的机器学习系统、用于验证诊断的神经网络，以及致力于发现隐藏模式和宝贵见解以改进药物开发的研究。包含算法。 它还包括复杂图像的检查、精确定位治疗区域并最大程度地减少侵入性手术过程中对健康组织的损害的不良症状分割解决方案，以及针对医疗专业人员和患者的沉浸式培训它还包括集成 3D 成像和虚拟现实 (VR) 设备的应用程序启用教育，高级诊断。 通过将先进技术融入图像解读管道，医疗保健行业可以应对与大量数据相关的挑战。 医学图像分析工具的定制软件开发是这一过程中的关键步骤。

医学图像分析软件市场的增长还受到慢性病发病率增加、老龄化社会对医疗服务需求增加以及计算机辅助诊断 (CAD) 等成像技术领域的持续开发的推动). 将被删除。 此外，老年人口的增加和越来越多地采用能够快速诊断慢性病的诊断超声成像系统预计将对市场扩张做出重大贡献。 此外，全球医学图像分析软件市场的增长预计将在很大程度上受到医学图像分析软件不断进步等因素的推动，从而导致市场增长。 全球医学图像分析软件市场的主要参与者正在投资于产品发布、收购、研发以推动医学图像分析软件的进步，以加强他们的市场地位并保持竞争环境。我们正在选择不同的策略，例如投资.

推动市场增长的主要因素包括对医学图像分析软件产品优势的认识显着提高、软件在医学图像分析中的使用率上升以及患病患者人数激增。它是 然而，存储数据的安全风险以及高昂的安装和维护成本阻碍了市场增长。 相反，人工智能 (AI) 在医学成像中的引入正在改变预测期内的市场动态，预计这将为市场增长提供有利可图的机会。 预计医学成像领域的广泛研发活动将为市场扩张开闢新途径，同时显着改善医疗基础设施。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 顶级影响因子
    • 顶级投资基金
  • 波特的五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争对手的实力
  • 市场动态
    • 司机
      • 慢性病患病率增加
      • 在图像处理技术领域的发展日新月异
      • 增加在医疗领域的使用
    • 约束因素
      • 存储数据的安全风险很高
    • 机会
      • 关于在医学影像诊断中引入人工智能 (AI)
  • 分析 COVID-19 对市场的影响

第 4 章医学图像分析软件市场：按类型

  • 概览
    • 市场规模和预测
  • 整合
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 独立的
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 5 章医学图像分析软件市场：按模态分类

  • 概览
    • 市场规模和预测
  • 计算机断层扫描
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 磁共振成像
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 超声波
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 多种方式
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 6 章医学图像分析软件市场：按应用

  • 概览
    • 市场规模和预测
  • 骨科
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 牙科
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 神经学
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 心脏病学
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 肿瘤学
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 7 章医学图像分析软件市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 诊断中心
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：国家/地区分析

第 8 章医学图像分析软件市场：按地区

  • 概览
    • 市场规模和预测：按地区
  • 北美
    • 主要趋势和机遇
    • 市场规模/预测：按类型
    • 市场规模和预测：按方式分类
    • 市场规模和预测：按应用
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
  • 欧洲
    • 主要趋势和机遇
    • 市场规模/预测：按类型
    • 市场规模和预测：按方式分类
    • 市场规模和预测：按应用
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 其他欧洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
  • 亚太地区
    • 主要趋势和机遇
    • 市场规模/预测：按类型
    • 市场规模和预测：按方式分类
    • 市场规模和预测：按应用
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模/预测：按方式
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 其他亚太地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
  • 拉美
    • 主要趋势和机遇
    • 市场规模/预测：按类型
    • 市场规模和预测：按方式分类
    • 市场规模和预测：按应用
    • 市场规模和预测：按最终用户分类
    • 市场规模/预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类
      • LAMEA 的其余部分
      • 主要市场趋势、增长动力和机遇
      • 市场规模/预测：按类型
      • 市场规模和预测：按方式分类
      • 市场规模和预测：按应用
      • 市场规模和预测：按最终用户分类

第9章竞争格局

  • 介绍
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 定位顶级公司，2021 年

第十章公司简介

  • Agfa Healthcare
  • CANON MEDICAL SYSTEMS CORPORATION
  • Coexya
  • ESAOTE SPA
  • GE Healthcare
  • IBM Corporation
  • Koninklijke Philips N.V.
  • MIM Software, Inc
  • Siemens Healthineers
  • Spacelabs Healthcare
Product Code: A11265

The medical image analysis software market was valued at $3.9 billion in 2021 and is projected to reach $12.3 billion by 2031, registering a CAGR of 12.2% from 2022 to 2031.  

The application of medical image analysis software enables quantitative analysis and visualization of medical images of numerous modalities such as PET, MRI, CT, or microscopy. The applications of enabling both manual and automated analysis of 3D medical images unlocks various opportunities to the benefit of providers and patients. It includes machine learning systems to facilitate early diagnostics for higher cure and survival rates, neural networks for diagnosis validation, research-specific algorithms to find hidden patterns and valuable insights to improve drug development. It may also include the examination of complex imaging types with adverse symptoms segmentation solutions to pinpoint a treatment area and thus minimizing possible damage to healthy tissue during an invasive procedure, applications integrating 3D imaging with virtual reality (VR) devices to enable immersive training of health specialists, patient education, and advanced diagnostics. Integrating advanced technologies into the image interpretation pipeline can help the healthcare sector address challenges associated with large amounts of data. Custom software development of medical image analysis tools is a critical step in this process. 

The growth of the medical image analysis software market is driven by increasing incidence of chronic diseases, rise in demand for health care services for the aging population, and continuous developments in the field of imaging technology, such as computer-aided diagnosis (CAD). Moreover, the rise in the geriatric population and growing adoption of ultrasound imaging systems to facilitate faster diagnosis of chronic diseases is expected to notably contribute toward the market growth. Furthermore, the global medical image analysis software market growth is largely driven by factors such as an increase in advancements of medical imaging software which is expected to lead to the growth of the market. Prominent players in the global medical image analysis software market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in medical image analysis software to strengthen their position in the market and sustain the competitive environment.  

A significant increase in awareness about the advantages of medical imaging software products, rise in the usage of software in medical imaging, and surge in the number of patients suffering from diseases are some of the key factors driving the growth of the market. However, the security risks of data stored concerns and high installation cost and maintenance hamper the market growth. Conversely, introduction of Artificial Intelligence (AI) in medical imaging has changed the market dynamics in the forecast period which is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical imaging along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market. 

The global medical image analysis software market is segmented based on type, modality, imaging type, application, end user, and region. On the basis of type, the market is classified into integrated and standalone. As per modalities, the market is classified into tomography, ultrasound imaging, radiographic imaging, and combined modalities. According to imaging type, the market is classified into 2D imaging, 3D imaging, and 4D imaging. Depending on application, the market is classified into orthopedic, dental, neurology, cardiology, oncology, obstetrics & gynecology, and others. By end user, the market is classified into hospitals, diagnostic centers, ambulatory surgical centers, and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major companies profiled in the report include: Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Spacelabs Healthcare, Agfa-Gevaert Group, MIM Software, Inc., Toshiba Medical Systems Corporation, ESAOTE SPA, Merge Healthcare, Inc., and Aquilab SAS. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical image analysis software market analysis from 2021 to 2031 to identify the prevailing medical image analysis software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical image analysis software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical image analysis software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Integrated
  • Stand-alone

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Combined Modalities
  • Others

By Application

  • Orthopedic
  • Dental
  • Neurology
  • Cardiology
  • Oncology
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • IBM Corporation
  • CANON MEDICAL SYSTEMS CORPORATION
  • Siemens Healthineers
  • ESAOTE SPA 
  • Coexya
  • MIM Software, Inc
  • Koninklijke Philips N.V. 
  • GE Healthcare
  • Spacelabs Healthcare
  • Agfa Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of chronic diseases
      • 3.4.1.2. Rise in developments in the field of imaging technology
      • 3.4.1.3. Increase in usage in medical applications
    • 3.4.2. Restraints
      • 3.4.2.1. High security risks of data stored
    • 3.4.3. Opportunities
      • 3.4.3.1. Introduction of Artificial Intelligence (AI) in medical imaging
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Integrated
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Stand-alone
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Computed Tomography
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Magnetic Resonance Imaging
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Ultrasound
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Combined Modalities
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Orthopedic
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Dental
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Neurology
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Cardiology
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country
  • 6.6. Oncology
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by region
    • 6.6.3. Market share analysis by country
  • 6.7. Others
    • 6.7.1. Key market trends, growth factors and opportunities
    • 6.7.2. Market size and forecast, by region
    • 6.7.3. Market share analysis by country

CHAPTER 7: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospitals
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Diagnostic Centers
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Type
    • 8.2.3. Market size and forecast, by Modality
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Type
      • 8.2.6.1.3. Market size and forecast, by Modality
      • 8.2.6.1.4. Market size and forecast, by Application
      • 8.2.6.1.5. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Type
      • 8.2.6.2.3. Market size and forecast, by Modality
      • 8.2.6.2.4. Market size and forecast, by Application
      • 8.2.6.2.5. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Type
      • 8.2.6.3.3. Market size and forecast, by Modality
      • 8.2.6.3.4. Market size and forecast, by Application
      • 8.2.6.3.5. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Type
    • 8.3.3. Market size and forecast, by Modality
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Type
      • 8.3.6.1.3. Market size and forecast, by Modality
      • 8.3.6.1.4. Market size and forecast, by Application
      • 8.3.6.1.5. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Type
      • 8.3.6.2.3. Market size and forecast, by Modality
      • 8.3.6.2.4. Market size and forecast, by Application
      • 8.3.6.2.5. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Type
      • 8.3.6.3.3. Market size and forecast, by Modality
      • 8.3.6.3.4. Market size and forecast, by Application
      • 8.3.6.3.5. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Type
      • 8.3.6.4.3. Market size and forecast, by Modality
      • 8.3.6.4.4. Market size and forecast, by Application
      • 8.3.6.4.5. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Type
      • 8.3.6.5.3. Market size and forecast, by Modality
      • 8.3.6.5.4. Market size and forecast, by Application
      • 8.3.6.5.5. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Type
      • 8.3.6.6.3. Market size and forecast, by Modality
      • 8.3.6.6.4. Market size and forecast, by Application
      • 8.3.6.6.5. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Type
    • 8.4.3. Market size and forecast, by Modality
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. China
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Type
      • 8.4.6.1.3. Market size and forecast, by Modality
      • 8.4.6.1.4. Market size and forecast, by Application
      • 8.4.6.1.5. Market size and forecast, by End User
      • 8.4.6.2. Japan
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Type
      • 8.4.6.2.3. Market size and forecast, by Modality
      • 8.4.6.2.4. Market size and forecast, by Application
      • 8.4.6.2.5. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Type
      • 8.4.6.3.3. Market size and forecast, by Modality
      • 8.4.6.3.4. Market size and forecast, by Application
      • 8.4.6.3.5. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Type
      • 8.4.6.4.3. Market size and forecast, by Modality
      • 8.4.6.4.4. Market size and forecast, by Application
      • 8.4.6.4.5. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Type
      • 8.4.6.5.3. Market size and forecast, by Modality
      • 8.4.6.5.4. Market size and forecast, by Application
      • 8.4.6.5.5. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Type
      • 8.4.6.6.3. Market size and forecast, by Modality
      • 8.4.6.6.4. Market size and forecast, by Application
      • 8.4.6.6.5. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Type
    • 8.5.3. Market size and forecast, by Modality
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Type
      • 8.5.6.1.3. Market size and forecast, by Modality
      • 8.5.6.1.4. Market size and forecast, by Application
      • 8.5.6.1.5. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Type
      • 8.5.6.2.3. Market size and forecast, by Modality
      • 8.5.6.2.4. Market size and forecast, by Application
      • 8.5.6.2.5. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Type
      • 8.5.6.3.3. Market size and forecast, by Modality
      • 8.5.6.3.4. Market size and forecast, by Application
      • 8.5.6.3.5. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Type
      • 8.5.6.4.3. Market size and forecast, by Modality
      • 8.5.6.4.4. Market size and forecast, by Application
      • 8.5.6.4.5. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. Agfa Healthcare
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. CANON MEDICAL SYSTEMS CORPORATION
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Coexya
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. ESAOTE SPA 
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
  • 10.5. GE Healthcare
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
  • 10.6. IBM Corporation
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
  • 10.7. Koninklijke Philips N.V. 
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
  • 10.8. MIM Software, Inc
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Siemens Healthineers
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
    • 10.9.7. Key strategic moves and developments
  • 10.10. Spacelabs Healthcare
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 02. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 05. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 11. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 23. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 24. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 29. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 30. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 33. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 36. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 44. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 45. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 54. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 55. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 56. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 57. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 58. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 62. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 66. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 67. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 70. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 71. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 73. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 74. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 75. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 79. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 83. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 84. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 86. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 87. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 88. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 91. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 94. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 97. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 98. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 99. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 102. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 103. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 104. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 105. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 106. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 107. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 108. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 109. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 110. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 111. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 112. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 113. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 115. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 116. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 117. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 118. AGFA HEALTHCARE: KEY EXECUTIVES
  • TABLE 119. AGFA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 120. AGFA HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 121. AGFA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 122. AGFA HEALTHCARE: KEY STRATERGIES
  • TABLE 123. CANON MEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 124. CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT SEGMENTS
  • TABLE 126. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127. CANON MEDICAL SYSTEMS CORPORATION: KEY STRATERGIES
  • TABLE 128. COEXYA: KEY EXECUTIVES
  • TABLE 129. COEXYA: COMPANY SNAPSHOT
  • TABLE 130. COEXYA: PRODUCT SEGMENTS
  • TABLE 131. COEXYA: PRODUCT PORTFOLIO
  • TABLE 132. COEXYA: KEY STRATERGIES
  • TABLE 133. ESAOTE SPA : KEY EXECUTIVES
  • TABLE 134. ESAOTE SPA : COMPANY SNAPSHOT
  • TABLE 135. ESAOTE SPA : PRODUCT SEGMENTS
  • TABLE 136. ESAOTE SPA : PRODUCT PORTFOLIO
  • TABLE 137. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 138. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 139. GE HEALTHCARE: SERVICE SEGMENTS
  • TABLE 140. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 141. IBM CORPORATION: KEY EXECUTIVES
  • TABLE 142. IBM CORPORATION: COMPANY SNAPSHOT
  • TABLE 143. IBM CORPORATION: SERVICE SEGMENTS
  • TABLE 144. IBM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 145. KONINKLIJKE PHILIPS N.V. : KEY EXECUTIVES
  • TABLE 146. KONINKLIJKE PHILIPS N.V. : COMPANY SNAPSHOT
  • TABLE 147. KONINKLIJKE PHILIPS N.V. : SERVICE SEGMENTS
  • TABLE 148. KONINKLIJKE PHILIPS N.V. : PRODUCT PORTFOLIO
  • TABLE 149. MIM SOFTWARE, INC: KEY EXECUTIVES
  • TABLE 150. MIM SOFTWARE, INC: COMPANY SNAPSHOT
  • TABLE 151. MIM SOFTWARE, INC: PRODUCT SEGMENTS
  • TABLE 152. MIM SOFTWARE, INC: PRODUCT PORTFOLIO
  • TABLE 153. SIEMENS HEALTHINEERS: KEY EXECUTIVES
  • TABLE 154. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
  • TABLE 155. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS
  • TABLE 156. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
  • TABLE 157. SIEMENS HEALTHINEERS: KEY STRATERGIES
  • TABLE 158. SPACELABS HEALTHCARE: KEY EXECUTIVES
  • TABLE 159. SPACELABS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 160. SPACELABS HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 161. SPACELABS HEALTHCARE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL IMAGE ANALYSIS SOFTWARE MARKET
  • FIGURE 10. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY COUNTRY 2021-2031(%)
  • FIGURE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 26. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 30. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY REGION, 2021
  • FIGURE 31. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 48. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 49. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2021
  • FIGURE 57. AGFA HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 58. AGFA HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. AGFA HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 60. CANON MEDICAL SYSTEMS CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. GE HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 64. GE HEALTHCARE: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 65. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 66. GE HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 67. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 68. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 69. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 70. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. KONINKLIJKE PHILIPS N.V. : NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 72. KONINKLIJKE PHILIPS N.V. : RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 73. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 74. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 75. SIEMENS HEALTHINEERS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 76. SIEMENS HEALTHINEERS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 77. SIEMENS HEALTHINEERS: REVENUE SHARE BY REGION, 2021 (%)